Skip to the content
halfrx
← All providers and medications

Compounded tirzepatide vs Saxenda (liraglutide)

Verdict

Saxenda is the better choice of the two, winning on regulatory and complaint risk and approved product or compounded copy (halfrx score 4.2 against 1.8).

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Compounded tirzepatide or Saxenda (liraglutide): which one has a price?

Only Compounded tirzepatide has an all-in figure here: $199–$359 a month, the range its sellers here charge, oldest read 2026-09-13. Saxenda (liraglutide) has none, so price cannot decide between them. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. Flags recorded here: Compounded tirzepatide — not FDA approved, manufacturer lawsuit, supply risk. Saxenda (liraglutide) is an FDA-approved product and Compounded tirzepatide is a compounded copy made under the pharmacy-compounding exemption, which is a legal status rather than a quality claim. The published formula scores them 1.8 and 4.2 out of 10, arithmetic over the same stored fields rather than an editor's preference. Cost here is scored on what a patient pays once titrated, never on the entry price, because an introductory rate covers the months before anybody has reached the dose they stay on.

Head to head

Compounded tirzepatide against Saxenda (liraglutide), one row per axis, with the side that wins each axis marked.
What decides itCompounded tirzepatide
$199–$359/mo
Saxenda
price unverified
Entry priceNot comparable — Saxenda (liraglutide) publishes no verified all-in price.not comparablenot comparable
Regulatory and complaint riskCompounded tirzepatide: 3 serious flags. Saxenda (liraglutide): none.—✓ better here
Approved product or compounded copySaxenda (liraglutide) supplies an FDA-approved product; Compounded tirzepatide supplies a compounded preparation, which the FDA does not review for safety, efficacy or quality and which can stop shipping if its pharmacy is enjoined.—✓ better here
Compounded tirzepatide publishes no page halfrx will send you toGo to Saxenda ↗

What separates these two, price aside

  • These are different molecules — tirzepatide against liraglutide — so this is a comparison of two treatments, not of two prices for one.
503A/503B compounding pharmacies
Compounded tirzepatide
1.8
$199–$359/mo all-in
checked 2026-09-13 — no maintenance-dose price
Not FDA approvedCompounding legal riskManufacturer lawsuitSupply risk
4.2
Price unverified
Weaker moleculeBoxed warning

Compounded tirzepatide

Pros

  • +Access to tirzepatide, the most effective molecule, at $199–$359/mo against Zepbound's $1,086 list.[1]
  • +Vial dosing allows finer titration than branded pens.[1]

Cons

  • −Not FDA approved — no review of safety, efficacy or manufacturing quality.[1]
  • −Eli Lilly has active lawsuits against compounded tirzepatide sellers, including Henry Meds. A ruling against your provider ends your supply.[2]
  • −The tirzepatide shortage that legally permitted mass compounding has been resolved, so the category now operates on contested legal ground.[2]
  • −Zepbound vials through LillyDirect start at $299/mo — the branded gap is far smaller than it was, which weakens the only argument for compounding.[1]

Saxenda (liraglutide)

Pros

  • +Longest safety record of any GLP-1 approved for weight, on the market since 2014.[1]
  • +Generic liraglutide has been sold in the US since Teva launched generic Saxenda on 28 August 2025, so a branded Saxenda price is no longer the only liraglutide price.[3]
  • +Approved for adolescents aged 12 and over, as Wegovy and Qsymia are; Zepbound is for adults only.[1]

Cons

  • −7.4% mean weight loss on its label's trial — half of Wegovy and about a third of Zepbound.[1]
  • −Daily injection rather than weekly. Seven times the injections for a worse result.[1]
  • −No seller on this site offers branded Saxenda at a published cash price; Wegovy is $349 a month direct from NovoCare, for about twice the trial weight loss.[1]

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Compounded tirzepatide

Everything on Saxenda

The registers and documents behind both sides

Two cards compared on the same checks. These are the registers those checks were run against, and the FDA's own pages where either side is a compounded product.

Compounded tirzepatide against Saxenda, answered

Is Compounded tirzepatide or Saxenda better for weight loss?
Only Saxenda has a trial figure recorded here: 7.4% average weight loss, from its own label trial. Compounded tirzepatide has none on this site — a compounded preparation has no trial of its own, so the two cannot be compared on effect and this page does not pick one on it.
Which is cheaper, Compounded tirzepatide or Saxenda?
Saxenda publishes no all-in monthly price that could be verified, so this page carries no comparison rather than an estimate — and an unpublished price is itself worth weighing.
Can you switch between Compounded tirzepatide and Saxenda?
They are different molecules, so this is a change of medication rather than of brand, and the one you move to is started on its own dosing schedule.
Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.